Bluemoor Health reports quarterly revenue above the internal plan
Bluemoor Health said demand in its Medical Devices segment held up through the quarter, with management reiterating full-year margin guidance.
Terminal Brief
Bluemoor Health
Healthcare · Medical Devices
Updated UTC
US$146.21
+1.91+1.32%
After hoursUS$145.56-0.44%
| Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | 126.29억 | 141.26억 | 151.94억 | 159.55억 | 172.57억 |
| Gross profit | 72.33억 | 84.28억 | 86.79억 | 92.77억 | 103.11억 |
| Operating income | 26.23억 | 31.17억 | 32억 | 29.87억 | 31.36억 |
| Net income | 18.66억 | 18.19억 | 23.78억 | 20.31억 | 24.89억 |
Develops remote-monitoring hardware and clinical software for chronic-care providers.
Bluemoor Health said demand in its Medical Devices segment held up through the quarter, with management reiterating full-year margin guidance.
Terminal Brief
The company approved a multi-year capital program intended to shorten lead times for its largest customers.
Market Wire
A sell-side desk kept a neutral rating while noting that near-term estimates already reflect steady execution.
Sector Desk
The board named an internal candidate with prior treasury and investor-relations experience to the role.
Market Wire
The authorization covers a modest slice of the float and will be funded from operating cash flow.
Market Wire